Amgen to Close Onyx Facility, Layoffs Follow

Amgen, which bought Onyx Pharmaceuticals in August 2013 for $10.4 billion, is shutting down the biopharmaceutical company's South San Francisco facility and plans to lay off about 300 people.

Source: Pharma Manufacturing
More...